Valneva shares dip after EU regulator comments on status of covid-19 vaccine approval

 

Shares in biotech firm Valneva dropped as much as 6.9% on Tuesday after the European Union drug regulator said the firm's COVID-19 vaccine was under an EU rolling review but it was still awaiting some additional data.

Valneva's share price has fluctuated sharply in recent weeks on news about the company's COVID-19 vaccine candidate.

https://www.marketscreener.com/quote/stock/VALNEVA-SE-54466/news/Valneva-shares-dip-after-EU-regulator-comments-on-status-of-covid-19-vaccine-approval-37577286/